Drug Shortage Report for ACT PROGESTERONE INJECTION
| Report ID | 149602 |
| Drug Identification Number | 02446820 |
| Brand name | ACT PROGESTERONE INJECTION |
| Common or Proper name | PROGESTERONE 500MG/10ML INJ |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGESTERONE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 |
| ATC code | G03DA |
| ATC description | PROGESTOGENS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2021-11-16 |
| Estimated end date | Unknown |
| Actual end date | 2025-04-07 |
| Shortage status | Resolved |
| Updated date | 2025-04-29 |
| Company comments | Discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2025-04-29 | French | Compare |
| v9 | 2025-04-29 | English | Compare |
| v8 | 2022-08-18 | French | Compare |
| v7 | 2022-08-18 | English | Compare |
| v6 | 2022-08-08 | French | Compare |
| v5 | 2022-08-08 | English | Compare |
| v4 | 2022-02-04 | French | Compare |
| v3 | 2022-02-04 | English | Compare |
| v2 | 2021-11-18 | French | Compare |
| v1 | 2021-11-18 | English | Compare |
Showing 1 to 10 of 10